Literature DB >> 32430309

Serology for SARS-CoV-2: Apprehensions, opportunities, and the path forward.

Juliet E Bryant1, Andrew S Azman2,3, Matthew J Ferrari4, Benjamin F Arnold5, Maciej F Boni4, Yap Boum6, Kyla Hayford2, Francisco J Luquero7, Michael J Mina8, Isabel Rodriguez-Barraquer9, Joseph T Wu10, Djibril Wade11, Guy Vernet12, Daniel T Leung13.   

Abstract

Serological testing for SARS-CoV-2 has enormous potential to contribute to COVID-19 pandemic response efforts. However, the required performance characteristics of antibody tests will critically depend on the use case (individual-level vs. population-level).
Copyright © 2020, American Association for the Advancement of Science.

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32430309     DOI： 10.1126/sciimmunol.abc6347

Source DB:  PubMed          Journal:  Sci Immunol        ISSN： 2470-9468


  60 in total

Review 1. 

Authors:  Paul Van Caeseele; Dana Bailey; Sarah E Forgie; Tanis C Dingle; Mel Krajden
Journal:  CMAJ       Date:  2020-12-07       Impact factor: 8.262

Review 2.  Recent advances in methods for the diagnosis of Corona Virus Disease 2019.

Authors:  Jie Guo; Jiaxin Ge; Yanan Guo
Journal:  J Clin Lab Anal       Date:  2021-12-17       Impact factor: 2.352

3.  TIPICO XI: report of the first series and podcast on infectious diseases and vaccines (aTIPICO).

Authors:  Federico Martinón-Torres; Adolfo García-Sastre; Andrew J Pollard; Carlos Martín; Albert Osterhaus; Shamez N Ladhani; Octavio Ramilo; Jose Gómez Rial; Antonio Salas; F Xavier Bosch; María Martinón-Torres; Michael J Mina; James Cherry
Journal:  Hum Vaccin Immunother       Date:  2021-11-11       Impact factor: 3.452

4.  Prevalence and predictors of anti-SARS-CoV-2 serology in a highly vulnerable population of Rio de Janeiro: A population-based serosurvey.

Authors:  Lara E Coelho; Paula M Luz; Débora C Pires; Emilia M Jalil; Hugo Perazzo; Thiago S Torres; Sandra W Cardoso; Eduardo M Peixoto; Sandro Nazer; Eduardo Massad; Mariângela F Silveira; Fernando C Barros; Ana T R Vasconcelos; Carlos A M Costa; Rodrigo T Amancio; Daniel A M Villela; Tiago Pereira; Guilherme T Goedert; Cleber V B D Santos; Nadia C P Rodrigues; Beatriz Grinsztejn; Valdilea G Veloso; Claudio J Struchiner
Journal:  Lancet Reg Health Am       Date:  2022-07-30

5.  Accurate SARS-CoV-2 seroprevalence surveys require robust multi-antigen assays.

Authors:  Christos Fotis; Nikolaos Meimetis; Nikos Tsolakos; Marianna Politou; Karolina Akinosoglou; Vaia Pliaka; Angeliki Minia; Evangelos Terpos; Ioannis P Trougakos; Andreas Mentis; Markos Marangos; George Panayiotakopoulos; Meletios A Dimopoulos; Charalampos Gogos; Alexandros Spyridonidis; Leonidas G Alexopoulos
Journal:  Sci Rep       Date:  2021-03-23       Impact factor: 4.379

6.  Implications of SARS-CoV-2-Associated Myocarditis in the Medical Evaluation of Athletes.

Authors:  Neha P Raukar; Leslie T Cooper
Journal:  Sports Health       Date:  2020-11-17       Impact factor: 3.843

Review 7.  Clinical Application of Serologic Testing for Coronavirus Disease 2019 in Contemporary Cardiovascular Practice.

Authors:  Abdulla A Damluji; Robert H Christenson; Christopher deFilippi
Journal:  J Am Heart Assoc       Date:  2021-02-23       Impact factor: 5.501

8.  Prevalence of COVID-19 in Iran: results of the first survey of the Iranian COVID-19 Serological Surveillance programme.

Authors:  Kazem Khalagi; Safoora Gharibzadeh; Davood Khalili; Mohammad Ali Mansournia; Siamak Mirab Samiee; Saeide Aghamohamadi; Maryam Mir-Mohammad-Ali Roodaki; Seyed Mahmoud Hashemi; Katayoun Tayeri; Hengameh Namdari Tabar; Kayhan Azadmanesh; Jafar Sadegh Tabrizi; Kazem Mohammad; Firoozeh Hajipour; Saeid Namaki; Alireza Raeisi; Afshin Ostovar
Journal:  Clin Microbiol Infect       Date:  2021-06-07       Impact factor: 8.067

9.  Nationwide population-based surveys of Iranian COVID-19 Serological Surveillance (ICS) program: The surveys protocol.

Authors:  Kazem Khalagi; Safoora Gharibzadeh; Davood Khalili; Siamak Mirab Samiee; Seyed Mahmoud Hashemi; Saeide Aghamohamadi; Maryam Mir-Mohammad-Ali Roodaki; Katayoun Tayeri; Hengameh Namdari Tabar; Kayhan Azadmanesh; Jafar Sadegh Tabrizi; Kazem Mohammad; Samira Goudarzi; Firoozeh Hajipour; Saeid Namaki; Alireza Raeisi; Afshin Ostovar
Journal:  Med J Islam Repub Iran       Date:  2021-05-12

10.  Potential Biases Arising From Epidemic Dynamics in Observational Seroprotection Studies.

Authors:  Rebecca Kahn; Lee Kennedy-Shaffer; Yonatan H Grad; James M Robins; Marc Lipsitch
Journal:  Am J Epidemiol       Date:  2021-02-01       Impact factor: 4.897
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.